Cyclerion Therapeutics, Inc. Common Stock (CYCN) stock analysis and AI prediction
The company facts of Cyclerion Therapeutics, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Cyclerion Therapeutics, Inc. Common Stock
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $18.7 million
- Size
- Micro cap
- Employees
- 1
- Headquarters
- CAMBRIDGE, MA
- Listed since
- March 18, 2019
- Website
- cyclerion.com
More Healthcare stocks
Other micro cap stocks
Keep going
CYCN questions
What is the AI prediction for CYCN stock?
Each market day our model rates Cyclerion Therapeutics, Inc. Common Stock (CYCN) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the CYCN prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for CYCN?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see CYCN options?
The CYCN options page opens its calls and puts, with price, volume, implied volatility and the Greeks.